Skip to content

Advertisement

  • Retraction Note
  • Open Access

Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

  • 1Email author,
  • 1,
  • 2,
  • 2, 3 and
  • 1, 2
Cancer Cell International201313:96

https://doi.org/10.1186/1475-2867-13-96

  • Received: 26 September 2013
  • Accepted: 26 September 2013
  • Published:

The original article was published in Cancer Cell International 2012 12:21

Retraction

This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.

Notes

Authors’ Affiliations

(1)
University of Lincoln, Brayford Pool, Lincoln, LN6 7TS, UK
(2)
Research & Development, Lincoln County Hospital, Greetwell Road, Lincoln, LN2 5QY, UK
(3)
Queens Medical Centre, University of Nottingham, Derby Road Nottingham, Nottingham, NG7 2UH, UK

References

  1. Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Jelly et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement